[go: up one dir, main page]

Turnbull et al., 2012 - Google Patents

Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery

Turnbull et al., 2012

View PDF
Document ID
10956361580304458378
Author
Turnbull I
Lieu D
Li R
Costa K
Publication year
Publication venue
Drug Discovery Today: Disease Models

External Links

Snippet

Cardiovascular disease (CVD) is the most prevalent health problem in the world, and the high mortality rate associated with irreversibly injured heart muscle motivates an urgent need for the development of novel therapies to treat damaged myocardium. Recently …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Similar Documents

Publication Publication Date Title
Bedada et al. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes
Jiang et al. Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations
Boudou et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues
US11299714B2 (en) Engineered adult-like human heart tissue
Zhao et al. The role of tissue engineering and biomaterials in cardiac regenerative medicine
Tiburcy et al. Modeling myocardial growth and hypertrophy in engineered heart muscle
Jackman et al. Human cardiac tissue engineering: from pluripotent stem cells to heart repair
Massai et al. Bioreactors as engineering support to treat cardiac muscle and vascular disease
JP2013520168A (en) Method for generating engineered innervating tissue and use thereof
Almeida et al. Human extracellular-matrix functionalization of 3D hiPSC-based cardiac tissues improves cardiomyocyte maturation
US12325867B2 (en) Organoid produced using carrier for cell culture, and method for evaluating drug toxicity using same
Truskey Development and application of human skeletal muscle microphysiological systems
Ralphe et al. 3D engineered cardiac tissue models of human heart disease: learning more from our mice
Tobita et al. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium
Smith et al. Skeletal muscle explants: Ex-vivo models to study cellular behavior in a complex tissue environment
Nakamura et al. Development and evaluation of a removable tissue-engineered muscle with artificial tendons
Oakley et al. Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy
Sesena-Rubfiaro et al. Membrane remodeling of human-engineered cardiac tissue by chronic electric stimulation
Turnbull et al. Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery
Ma et al. Tissue-engineering for the study of cardiac biomechanics
Amesz et al. Living myocardial slices: Advancing arrhythmia research
Gu et al. Recent advances in maturation of pluripotent stem cell-derived cardiomyocytes promoted by mechanical stretch
Neef et al. Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium
Kałużna et al. Modeling the human heart ex vivo—current possibilities and strive for future applications
Santoni et al. Microsystems for electromechanical stimulations to engineered cardiac tissues